C
The Cigna Group CI
$352.39 $3.611.04%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
C
Hold 3/1/2024Downgrade
The Cigna Group (CI) was downgraded to C+ from B- on 3/1/2024 due to a significant decline in the growth index, valuation index and efficiency index. Operating cash flow declined 48.09% from $2.83B to $1.47B, net income declined 26.92% from $1.41B to $1.03B, and earnings per share declined from $4.74 to $3.4907.
B
Buy 1/16/2024Upgraded
The Cigna Group (CI) was upgraded to B- from C+ on 1/16/2024 due to an increase in the total return index, solvency index and volatility index.
C
Hold 12/1/2023Downgrade
The Cigna Group (CI) was downgraded to C+ from B- on 12/1/2023 due to a noticeable decline in the total return index and solvency index.
B
Buy 11/3/2023Downgrade
The Cigna Group (CI) was downgraded to B- from B on 11/3/2023 due to a noticeable decline in the valuation index, growth index and efficiency index. Earnings per share declined from $4.92 to $4.74, net income declined 3.56% from $1.46B to $1.41B, and total capital declined 1.73% from $78.26B to $76.91B.
B
Buy 8/25/2023Upgraded
The Cigna Group (CI) was upgraded to B from B- on 8/25/2023 due to a major increase in the growth index, total return index and solvency index. Earnings per share increased from $4.24 to $4.92, EBIT increased 15.15% from $1.95B to $2.24B, and total revenue increased 4.63% from $46.46B to $48.61B.
B
Buy 4/6/2023Downgrade
The Cigna Group (CI) was downgraded to B- from B on 4/6/2023 due to a significant decline in the total return index and growth index. Earnings per share declined from $8.97 to $3.8276, operating cash flow declined 36.06% from $3.28B to $2.1B, and EBIT declined 16.16% from $2.07B to $1.73B.
B
Buy 1/19/2023Upgraded
Cigna Corporation (CI) was upgraded to B from B- on 1/19/2023 due to an increase in the total return index, volatility index and valuation index.
B
Buy 12/12/2022Downgrade
Cigna Corporation (CI) was downgraded to B- from B on 12/12/2022 due to a major decline in the growth index, volatility index and dividend index. EBIT declined 10.09% from $2.3B to $2.07B, and total revenue declined 0.41% from $45.39B to $45.2B.
B
Buy 9/21/2022Downgrade
Cigna Corporation (CI) was downgraded to B from B+ on 9/21/2022 due to a noticeable decline in the total return index.
B
Buy 8/19/2022Upgraded
Cigna Corporation (CI) was upgraded to B+ from B on 8/19/2022 due to a large increase in the total return index, growth index and volatility index. Earnings per share increased from $3.68 to $4.9, EBIT increased 22.03% from $1.88B to $2.3B, and total revenue increased 3.89% from $43.69B to $45.39B.
B
Buy 7/6/2022Upgraded
Cigna Corporation (CI) was upgraded to B from B- on 7/6/2022 due to a noticeable increase in the total return index, growth index and volatility index. Earnings per share increased from $3.3846 to $3.68, and EBIT increased 1.34% from $1.86B to $1.88B.
B
Buy 5/1/2022Upgraded
Cigna Corporation (CI) was upgraded to B- from C+ on 5/1/2022 due to an increase in the total return index, volatility index and growth index.
C
Hold 2/28/2022Downgrade
Cigna Corporation (CI) was downgraded to C+ from B- on 2/28/2022 due to a substantial decline in the growth index, valuation index and solvency index. Earnings per share declined from $4.8 to $3.3846, EBIT declined 21.03% from $2.35B to $1.86B, and the quick ratio declined from 0.58 to 0.48.
B
Buy 1/7/2022Upgraded
Cigna Corporation (CI) was upgraded to B- from C+ on 1/7/2022 due to an increase in the total return index, efficiency index and volatility index. Net income increased 10.5% from $1.47B to $1.62B.
C
Hold 9/21/2021Downgrade
Cigna Corporation (CI) was downgraded to C+ from B- on 9/21/2021 due to a decline in the volatility index.
B
Buy 3/11/2021Upgraded
Cigna Corporation (CI) was upgraded to B- from C+ on 3/11/2021 due to a large increase in the valuation index, total return index and volatility index.
C
Hold 1/21/2021Upgraded
Cigna Corporation (CI) was upgraded to C+ from C on 1/21/2021 due to an increase in the volatility index and solvency index. Debt to equity declined from 0.77 to 0.75.
C
Hold 8/24/2020Downgrade
Cigna Corporation (CI) was downgraded to C from C+ on 8/24/2020 due to a decline in the volatility index, valuation index and total return index.
C
Hold 8/7/2020Upgraded
Cigna Corporation (CI) was upgraded to C+ from C on 8/7/2020 due to a noticeable increase in the growth index, valuation index and volatility index. Operating cash flow increased 73.5% from $1.89B to $3.27B, earnings per share increased from $3.15 to $4.73, and EBIT increased 32.31% from $2.11B to $2.79B.
C
Hold 8/5/2020Downgrade
Cigna Corporation (CI) was downgraded to C from C+ on 8/5/2020 due to a decline in the volatility index and total return index.
C
Hold 7/1/2020Upgraded
Cigna Corporation (CI) was upgraded to C+ from C on 7/1/2020 due to an increase in the valuation index, volatility index and total return index.
C
Hold 6/12/2020Downgrade
Cigna Corporation (CI) was downgraded to C from C+ on 6/12/2020 due to a noticeable decline in the volatility index, valuation index and growth index. Operating cash flow declined 32.44% from $2.79B to $1.89B, and EBIT declined 14.69% from $2.47B to $2.11B.
C
Hold 3/6/2020Downgrade
Cigna Corporation (CI) was downgraded to C+ from B- on 3/6/2020 due to a decline in the total return index and solvency index. The quick ratio declined from 0.51 to 0.41.
B
Buy 2/26/2020Upgraded
Cigna Corporation (CI) was upgraded to B- from C+ on 2/26/2020 due to a noticeable increase in the total return index and volatility index.
C
Hold 2/4/2020Upgraded
Cigna Corporation (CI) was upgraded to C+ from C on 2/4/2020 due to a large increase in the growth index, volatility index and efficiency index. Operating cash flow increased 136.86% from $1.04B to $2.46B, and total capital increased 0.51% from $83.72B to $84.14B.
C
Hold 4/25/2019Downgrade
Cigna Corporation (CI) was downgraded to C from C+ on 4/25/2019 due to a decline in the volatility index and total return index.
C
Hold 4/3/2019Downgrade
Cigna Corporation (CI) was downgraded to C+ from B- on 4/3/2019 due to a noticeable decline in the total return index, growth index and volatility index. Earnings per share declined from $3.14 to $0.5467, operating cash flow declined 79.81% from $624M to $126M, and EBIT declined 24.98% from $1.27B to $949M.
B
Buy 1/7/2019None
The Cigna Group (CI) was downgraded to B- from U on 01/07/2019.
Weiss Ratings